Top 10 ASX Dividend Stocks for Nov 2026 Download Free Report

Healthcare

Life Sciences Companies Face Diverging Operating Milestones

Each company is assessed on its own reporting calendar andBusinessmodel. The discussion below retains company-reported financial measures and announced plans while separating those facts from assumptions about future outcomes.

Aditi Sarkar | 14 September 2026

ASX Healthcare Spotlight: Could Optiscan Imaging (ASX:OIL) Be a September 2026 Stock to Watch?

On 10 September 2026 Optiscan told the market it had reached a significant milestone in its ACL digital pathology study. The company reported an 84-case imaging milestone for its InForm device, describing the work as advancing preparation for a planned submission to the United …

Aditi Sarkar | 14 September 2026

ASX Healthcare Spotlight: Could Emvision Medical Devices (ASX:EMV) Be a September 2026 Stock to Watch?

On 31 August 2026 EMVision announced that recruitment into the pivotal trial of its emu bedside scanner had surpassed 200 patients. Pivotal trials are the studies regulators rely on when assessing a device, so recruitment progress is the clearest available indicator of how close …

Aditi Sarkar | 14 September 2026

Nyrada (ASX:NYR) on the Radar: What Could Drive the Next Move in September 2026?

On 21 August 2026 Nyrada announced that Xolatryp demonstrated cardioprotection in a preclinical study. Small Caps reported the underlying work as a rat model of acute myocardial ischaemia-reperfusion injury, in which the candidate showed high efficacy in limiting cardiovascular damage, positioning it as a …

Aditi Sarkar | 14 September 2026

Why Paradigm Biopharmaceuticals (ASX:PAR) Could Be an ASX Biotech Stock to Watch This September

Paradigm lodged four announcements on 11 September 2026. The substantive one was the drawdown of tranche 4 under its convertible note facility, accompanied by an application for quotation of securities, a notice under section 708A of the Corporations Act and a notification regarding unquoted …

Aditi Sarkar | 14 September 2026

Aroa Biosurgery (ASX:ARX) in Focus: Could This ASX Biotech Stock Be One to Watch in September 2026?

On 3 September 2026 Aroa released an interim analysis from the MASTRR Registry, which it described as the largest published prospective analysis of a bioscaffold used in in-patient soft tissue reconstruction. The results appeared in theJournalAdvances in Therapy.

Aditi Sarkar | 14 September 2026

Orthocell (ASX:OCC) on the Radar: What Could Drive the Next Move in September 2026?

On 13 July 2026 Orthocell announced record FY2026 results, headlined by record quarterly revenue of A$3.8 million for the June 2026 quarter — a 20 per cent increase on the March 2026 quarter and 36 per cent higher than the prior corresponding quarter. An …

Aditi Sarkar | 14 September 2026

PYC Therapeutics (ASX:PYC): A 93% One-Year Gain Raises the Bar for Clinical Progress

PYC Therapeutics is a clinical-stage biotechnology company developing RNA-based therapies for genetic diseases. Its platform combines designed RNA therapeutics with cell-penetrating peptides intended to deliver treatment inside target cells. The pipeline covers autosomal dominant optic atrophy, retinitis pigmentosa type 11, polycystic kidney disease and …

Aditi Sarkar | 12 September 2026

4DMedical (ASX:4DX): A 78% One-Year Gain Sharpens Focus on Clinical Adoption

4DMedical develops software-based lung imaging and analysis products. Its portfolio includes CT:VQ for non-contrast ventilation and perfusion imaging, CT LungVolumeAnalysis, lung-density tools, pulmonary hypertension assessment and XV Lung Ventilation Analysis. The company uses imaging data to provide functional information intended to support clinical assessment. …

Aditi Sarkar | 12 September 2026

Sims (ASX:SGM): An 82% One-Year Rise Puts Cash Returns and Recycling Margins Centre Stage

Sims is a global metal recycler and provider of circular services for digital infrastructure. Sims Metal collects and processes ferrous and non-ferrous material, while Sims Lifecycle Services manages technologyAssetsand supports data-centre infrastructure services. The group operates across multiple countries and also participates in the …

Aditi Sarkar | 12 September 2026
Support

Hi! How can we help you today?

Loading…